Physician profile
Jing Wang
NPI 1376856633
$512.77
in general payments reported to CMS, 2019-2025
9 companies · $236 in 2025
The $236 reported for 2025 was more than what 79% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.22 · 2022: $106 · 2023: $64.24 · 2024: $75.00 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $250 · Food and Beverage: $117 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $250.00 |
| Food and Beverage | $116.54 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $186.07 | 2023-2025 | Invisalign, Itero Element 5d Plus |
| Zimvie INC. | $159.78 | 2022-2025 | |
| Intercept Pharmaceuticals, INC. | $47.29 | 2021-2023 | Ocaliva |
| Orapharma, A Division of Bausch Health US, LLC | $37.84 | 2022 | |
| Kerr Corporation | $20.58 | 2022 | |
| Envista Holdings Corporation | $19.80 | 2025 | Artiste Compositetint |
| Philips North America LLC | $14.74 | 2023 | |
| Dentsply Sirona INC | $13.56 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jing Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.